A nomogram was constructed based on key predictors of OS in HCC, including T stage, M stage, pathological stage, and EZH2 expression, to further validate the prognostic significance of EZH2 on survival rates at 1, 3, and 5 years. This evidence concerns the gene EZH2 and hepatocellular carcinoma.